A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group.
- 15 December 1997
- journal article
- clinical trial
- Vol. 90 (12), 4710-8